Primary failure after surgery (PSA >0.2). ADT, androgen deprivation therapy; BCR, biochemical recurrence; EBRT, external beam radiotherapy; NGI, next-generation imaging; PSA, prostate-specific antigen; RP, radical prostatectomy; SADT, salvage androgen deprivation therapy.